BDBM479522 N-((3-amino-5-(4-fluorophenyl)-6-(1- methyl-6-oxo-1,6-dihydropyridin-3-yl) pyrazin-2-yl)methyl)-2,6- difluorobenzamide::US10898481, Compound 88::US11571420, Compound 88

SMILES Cn1cc(ccc1=O)-c1nc(CNC(=O)c2c(F)cccc2F)c(N)nc1-c1ccc(F)cc1

InChI Key InChIKey=CTYHRYNERQNNPE-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 479522   

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM479522(N-((3-amino-5-(4-fluorophenyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 2.40nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
TBA

US Patent
LigandPNGBDBM479522(N-((3-amino-5-(4-fluorophenyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 2.40nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM479522(N-((3-amino-5-(4-fluorophenyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 17nMAssay Description:The compounds at different concentrations were incubate with hA1 membrane (from PerkinElmer) and [3H]-8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
TBA

US Patent
LigandPNGBDBM479522(N-((3-amino-5-(4-fluorophenyl)-6-(1- methyl-6-oxo-...)
Affinity DataIC50: 17nMAssay Description:Binding affinity and specificalities of the compounds against different subtype of human adenosine receptors (hA1, hA2a, hA2b, and hA3) were characte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent